Feedback / Questions
B244 topical - AOBiome
https://www.prnewswire.com/news-releases/aob-pharma-receives-european-medicines-agency-ema-positive-decision-on-the-pediatric-investigation-plan-pip-supporting-future-development-of-b244-for-the-treatment-of-mild-to-moderate-atopic-dermatitis-in-children-adolescent-302627277.html
Dec 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next